TUDOR INVESTMENT CORP ET AL - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 259 filers reported holding AMICUS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,483
+122.7%
133,697
+145.0%
0.02%
+76.9%
Q4 2022$666
-99.4%
54,577
+333.9%
0.01%
+550.0%
Q3 2021$120,000
-80.8%
12,579
-80.1%
0.00%
-84.6%
Q1 2021$625,000
-41.3%
63,292
+37.2%
0.01%
-56.7%
Q4 2020$1,065,000
+384.1%
46,142
+195.9%
0.03%
+200.0%
Q3 2020$220,000
-54.1%
15,596
-68.3%
0.01%
-52.4%
Q4 2019$479,000
+97.1%
49,156
+62.2%
0.02%
+162.5%
Q3 2019$243,000
-91.0%
30,305
-86.1%
0.01%
-89.6%
Q2 2019$2,712,000
+255.9%
217,276
+173.3%
0.08%
+413.3%
Q4 2018$762,000
+72.4%
79,495
+117.2%
0.02%
+36.4%
Q3 2018$442,000
-33.7%
36,597
-14.3%
0.01%
-52.2%
Q2 2018$667,000
+437.9%
42,724
+246.4%
0.02%
+475.0%
Q2 2017$124,000
-51.4%
12,332
-76.0%
0.00%
-42.9%
Q4 2016$255,000
-35.9%
51,290
-29.7%
0.01%
-12.5%
Q2 2016$398,000
+178.3%
72,981
+330.6%
0.01%
+100.0%
Q1 2016$143,000
-73.6%
16,950
-56.2%
0.00%
-77.8%
Q3 2015$542,000
-64.0%
38,735
-63.6%
0.02%
-59.1%
Q2 2015$1,505,000
+1094.4%
106,356
+815.3%
0.04%
+1000.0%
Q1 2015$126,000
-84.6%
11,620
-88.2%
0.00%
-86.2%
Q4 2014$820,000
+76.3%
98,522
+26.2%
0.03%
+70.6%
Q3 2014$465,00078,0790.02%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Palo Alto Investors LP 10,524,022$127,972,10812.11%
Perceptive Advisors 27,692,917$336,745,87011.23%
Redmile Group, LLC 16,944,621$206,046,5919.80%
Finepoint Capital LP 1,489,025$18,106,5449.02%
CM Management, LLC 450,000$5,472,0005.81%
Avoro Capital Advisors LLC 27,400,000$333,184,0005.20%
MPM BioImpact LLC 716,139$8,708,2502.32%
Artal Group S.A. 4,062,567$49,4012.12%
SECTORAL ASSET MANAGEMENT INC 803,464$9,770,1221.90%
GREAT POINT PARTNERS LLC 857,000$10,421,1201.90%
View complete list of AMICUS THERAPEUTICS INC shareholders